Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
ID: 349895Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349895

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-270.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Aug 16, 2023, 12:00 AM UTC
  4. 4
    Due May 7, 2027, 12:00 AM UTC
Description

The National Institutes of Health (NIH) is offering a funding opportunity for innovative approaches to Screening, Brief Intervention, and Referral to Treatment or Prevention (SBIRT/P) targeting alcohol, tobacco, and other drugs (ATOD) use and misuse among adult populations experiencing health disparities. This initiative aims to enhance the implementation and effectiveness of SBIRT/P interventions through research that addresses barriers and fosters collaboration between healthcare providers and community partners. The funding opportunity is part of a strategic effort to improve health outcomes by addressing social determinants of health and ensuring better access to quality services for underserved populations. Interested applicants must submit their proposals by February 5, 2024, with a maximum project period of five years, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
PAR-23-270-Full-Announcement.html
Aug 24, 2024, 2:22 AM UTC
PAR-23-270.html
Aug 24, 2024, 2:22 AM UTC
The Department of Health and Human Services, via the National Institutes of Health, issued a Notice of Funding Opportunity (NOFO) focused on innovative approaches to Screening, Brief Intervention, and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD). Targeted at adult populations experiencing health disparities, the initiative emphasizes research to enhance the implementation and effectiveness of SBIRT/P interventions. It seeks proposals that foster collaboration between healthcare providers and community partners for improved outreach and sustainability. Key funding details include an application deadline of February 5, 2024, with a maximum project period of five years. Eligible entities range from higher education institutions to various nonprofits and governmental organizations. The primary research should address barriers to effective implementation of SBIRT/P, incorporating diverse perspectives in project plans. Applicants are encouraged to propose solutions to improve accessibility and quality of services provided to designated health disparity populations. This NOFO reflects a strategic effort to improve health outcomes through evidence-based, community-focused interventions, while addressing the broader social determinants that contribute to disparities in health. The initiative builds on findings that indicate insufficient funding has previously been allocated to address leading risk factors affecting these populations.
Similar Opportunities
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity for research projects focused on implementing Screening, Brief Intervention, and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use among adult populations experiencing health disparities. The initiative aims to develop innovative strategies to enhance the effectiveness of SBIRT/P, particularly targeting disadvantaged groups such as racial and ethnic minorities, rural communities, and individuals with disabilities. This funding is part of a broader effort to address health inequities related to substance use disorders and requires strong partnerships with healthcare and community organizations. Interested applicants must adhere to NIH application guidelines, including a Plan for Enhancing Diverse Perspectives (PEDP), and submit their proposals by May 7, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-26-001.html.
Alcohol Health Services Research (R34 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)" (PAR-23-252). This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on improving access to treatment, reducing stigma, examining cost structures, and implementing evidence-based approaches, particularly for health disparity populations. The total project budget is capped at $450,000 over a three-year period, and eligible applicants include higher education institutions, nonprofits, and government agencies, with a specific emphasis on those serving underrepresented communities. Interested parties should submit their applications electronically by October 16, 2023, with funding available until September 8, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders" (R34 Clinical Trial Optional). This initiative encourages pilot studies aimed at preparing for larger-scale effectiveness trials that focus on optimizing access, quality, and affordability of substance use disorder treatments and related services, with an emphasis on diverse perspectives through a Plan for Enhancing Diverse Perspectives (PEDP). Applicants may request up to $450,000 in direct costs for a three-year grant, with application due dates beginning January 16, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-100.html.
Alcohol Health Services Research (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R01 Clinical Trial Optional)" aimed at addressing the treatment gap for individuals with Alcohol Use Disorder (AUD). This initiative focuses on five key areas: increasing access to treatment, enhancing the appeal of treatment options, analyzing cost structures and insurance systems, studying the dissemination of evidence-based practices, and reducing health disparities among affected populations. The program encourages innovative research designs and participation from diverse organizations, with a maximum budget of $500,000 available for direct costs over a five-year project period. Interested applicants can submit proposals starting January 5, 2025, and should direct inquiries to grantsinfo@nih.gov for further information.
Alcohol Health Services Research (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the Alcohol Health Services Research (R01 Clinical Trial Optional) grant. This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing the appeal of treatment, examining cost structures and insurance systems, studying the dissemination and implementation of evidence-based approaches, and reducing health disparities among affected populations. The grant allows for a maximum budget of $500,000 and a project period of up to five years, with applications due by September 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has announced a funding opportunity for the Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional), aimed at supporting research in the development and testing of behavioral treatments for substance misuse and dependence. This grant focuses on Stage I research, which includes the development and pilot testing of novel interventions or the refinement of existing treatments, with an emphasis on scalability and effectiveness in community applications. The initiative is crucial for advancing effective treatment methods for substance use disorders, ensuring they are robust and applicable to diverse populations. Eligible applicants can receive up to $450,000 for a three-year project period, with applications due by May 7, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-300.html.
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials," aimed at encouraging pilot research to develop and test interventions that prevent or delay substance use. The initiative focuses on the creation and pilot testing of new or adapted strategies to curb substance misuse, particularly among underserved populations, while also addressing related negative outcomes such as impaired driving and transmission of infectious diseases. Eligible applicants include a wide range of institutions, such as academic, nonprofit, and government organizations, with funding available up to $450,000 over three years. Interested parties should note that applications are due starting January 16, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity aimed at small business concerns (SBCs) to develop technologies that address health-related social needs impacting substance use disorders (SUD), excluding alcohol use disorder. This initiative, titled "Seeking Products to Address Social Needs impacting SUD," invites applications for Small Business Technology Transfer (STTR) grants under phases I and II, with a total funding amount of $1.3 million available for four awards in FY 2025. The focus is on leveraging innovative technologies, such as telemedicine and mobile health applications, to improve conditions like housing instability and food insecurity that influence SUD outcomes. Interested applicants must comply with specific eligibility criteria and application guidelines, with a submission deadline of March 13, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the full announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-047.html.
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled the Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) aimed at advancing research in behavioral and integrative treatments for substance use and dependence. This program encourages the development and testing of innovative behavioral therapies through a structured approach that includes intervention generation, efficacy testing in research settings, and real-world efficacy assessments, with a focus on diverse populations and the use of technology. The funding amount is contingent on NIH appropriations, with a maximum project period of five years, and applications are due by February 5, 2025. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-299.html.
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity aimed at supporting small business concerns (SBCs) in developing technologies that address health-related social needs impacting substance use disorders (SUD), excluding alcohol use disorder. The initiative seeks innovative products that tackle core social determinants such as housing instability, food insecurity, and personal safety, with an emphasis on integrating technology like telemedicine and health applications to enhance access and reduce treatment barriers for at-risk populations. A total funding amount of $2 million is available, with specific allocations for Phase I and Phase II applications, and the deadline for submission is March 13, 2026, with letters of intent recommended 30 days prior. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the full announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-048.html.